Intrigued by reports that autophagy in tumors could be immunogenic (Ladoire et al., 2016a, 2016b; Michaud et al., 2011; Pietrocola et al., 2016), we investigated the possibility that IM ± anti-VEGF therapy might be attracting CD8 T cells, by analyzing tumors from mono- and combination therapy cohorts in LVRshp53 and PDG GBM models. The gene discussed is CD8A; the disease is glioblastoma.